Genetics

Mayo Clinic researchers will now be able to employ Complete Genomics ... from consenting patients to optimize medical care in a variety of disciplines, including cancer diagnosis and treatment, drug therapy, disease prevention, and many others.  

Complete Genomics Inc. (Nasdaq: GNOM) 46.8% HIGHER; announced today that it has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics' sequencing service for some of its large-scale whole genome sequencing projects. Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) 36% LOWER; announced that during a...  

Complete Genomics Inc. (Nasdaq: GNOM) 36% HIGHER; announced today that it has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics' sequencing service for some of its large-scale whole genome sequencing projects. Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) 35.5% LOWER; announced that during a...  

BGI opens genome research center in EuropeEurekAlert (press release)February 10th, 2012, Copenhagen, Denmark, and Shenzhen, China – BGI, the world's largest genomics organization, today opens its first European Genome Research Center located in Copenhagen Bio Science Park (COBIS). This research center is about 1200 ...and more »  

Scientists searching for the genomics version of the holy grail -- more insight into predicting how an animal's genes affect physical or behavioral traits -- now have a reference manual that should speed gene discoveries in everything from pest control to personalized medicine.  

Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. Genome Res. doi:10.1101/gr.118919.110 4. Cutting-edge methods to detect the genes and networks that drive cancer The special Cancer ...  

Norway to bring cancer-gene tests to the clinic: Norway is set to become the first country to incorporate genome sequencing into its national health-care system. The Scandinavian nation, which has a population of 4.8 million, will use ‘next-generation ...